A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
DR. MARTENS PLC ORD GBP0.01 operates in the Apparel - Footwear & Accessories industry, Consumer Cyclical sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 1.0B | 1.0B | 1.1B | 1.2B | 1.1B | 1.1B |
| Net Income | 5.9M | 5.9M | 89M | 161M | 223M | 48M |
| EPS | $0.01 | $0.01 | $0.09 | $0.16 | $0.22 | $0.05 |
| Free Cash Flow | 248M | 248M | 192M | 41M | 208M | 204M |
| ROIC | 9.9% | 6.2% | 15.6% | 23.4% | 41.0% | 23.4% |
| Gross Margin | 65.0% | 65.0% | 65.6% | 61.8% | 63.7% | 60.9% |
| Debt/Equity | 0.00 | 0.68 | 0.80 | 1.05 | 1.15 | 2.34 |
| Dividends/Share | $0.01 | $0.01 | $0.03 | $0.07 | $0.07 | - |
| Operating Income | 54M | 54M | 160M | 222M | 283M | 153M |
| Operating Margin | 5.2% | - | - | - | - | - |
| ROE | 1.2% | 1.2% | 18.1% | 35.4% | 73.2% | 23.2% |
| Shares Outstanding | 900M | 900M | 989M | 999M | 1,001M | 991M |
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 1.1B | 1.1B | 1.2B | 1.1B | 1.0B | 1.0B |
| Gross Margin | 60.9% | 63.7% | 61.8% | 65.6% | 65.0% | 65.0% |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | -494M | -431M | -552M | -580M | -627M | -627M |
| EBIT | 153M | 283M | 222M | 160M | 54M | 54M |
| Op. Margin | N/A | N/A | N/A | N/A | N/A | 5.2% |
| Net Income | 48M | 223M | 161M | 89M | 5.9M | 5.9M |
| Net Margin | 4.5% | 19.9% | 12.9% | 7.9% | 0.6% | 0.6% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | ||||||
| ROIC | 23.4% | 41.0% | 23.4% | 15.6% | 6.2% | 9.9% |
| ROE | 23.2% | 73.2% | 35.4% | 18.1% | 1.2% | 1.2% |
| ROA | 5.3% | 22.9% | 14.0% | 7.2% | 0.5% | 0.5% |
| Cash Flow | ||||||
| Op. Cash Flow | 218M | 227M | 91M | 215M | 259M | 259M |
| Free Cash Flow | 204M | 208M | 41M | 192M | 248M | 248M |
| Owner Earnings | 155M | 176M | 22M | 117M | 148M | 148M |
| CapEx | 14M | 19M | 49M | 23M | 11M | 11M |
| Maint. CapEx | 48M | 45M | 68M | 92M | 101M | 101M |
| Growth CapEx | 0 | 0 | 0 | 0 | 0 | 0 |
| D&A | 48M | 45M | 68M | 92M | 101M | 101M |
| CapEx/OCF | 6.5% | 8.4% | 54.5% | 10.8% | 4.3% | 4.3% |
| Capital Allocation | ||||||
| Dividends Paid | 0 | 15M | 73M | 74M | 13M | 13M |
| Dividend Yield | N/A | 0.5% | 4.1% | 7.8% | 1.4% | 2.1% |
| Share Buybacks | 0 | 0 | 0 | 65M | 0 | 0 |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 7.1% | 0.0% | 0.0% |
| Stock-Based Comp | 16M | 6.4M | 624K | 5.1M | 9.5M | 9.5M |
| Debt Repayment | 0 | 0 | 0 | 0 | 374M | 374M |
| Balance Sheet | ||||||
| Net Debt | 325M | 182M | 333M | 235M | 123M | -206M |
| Cash & Equiv. | 156M | 281M | 197M | 142M | 206M | 206M |
| Long-Term Debt | N/A | N/A | N/A | 366M | 325M | 325M |
| Debt/Equity | 2.34 | 1.15 | 1.05 | 0.80 | 0.68 | 0.00 |
| Interest Coverage | 2.7 | 15.2 | 9.5 | 3.9 | 1.3 | 1.3 |
| Equity | 206M | 405M | 504M | 471M | 484M | 484M |
| Total Assets | 896M | 1.1B | 1.2B | 1.2B | 1.2B | 1.2B |
| Total Liabilities | 690M | 654M | 734M | 747M | 691M | 691M |
| Intangibles | N/A | N/A | N/A | N/A | N/A | N/A |
| Retained Earnings | 2.1B | 2.1B | 2.2B | 2.2B | 2.3B | 2.3B |
| Working Capital | 168M | 356M | 430M | 363M | 333M | 333M |
| Current Assets | 378M | 547M | 635M | 559M | 542M | 542M |
| Current Liabilities | 209M | 191M | 205M | 196M | 209M | 209M |
| Per Share Data | ||||||
| EPS | 0.05 | 0.22 | 0.16 | 0.09 | 0.01 | 0.01 |
| Owner EPS | 0.16 | 0.18 | 0.02 | 0.12 | 0.16 | 0.16 |
| Book Value | 0.21 | 0.40 | 0.50 | 0.48 | 0.54 | 0.54 |
| Cash Flow/Share | 0.22 | 0.23 | 0.09 | 0.22 | 0.29 | 0.12 |
| Dividends/Share | N/A | 0.07 | 0.07 | 0.03 | 0.01 | 0.01 |
| Shares Out. | 991.4M | 1.0B | 999.2M | 988.6M | 900.0M | 900.0M |
| Valuation | ||||||
| P/E Ratio | 108.7 | 9.8 | 7.0 | 10.3 | 153.5 | 99.7 |
| P/FCF | 25.4 | 10.5 | 27.3 | 4.8 | 3.7 | 2.4 |
| EV/EBIT | 36.0 | 8.4 | 6.6 | 7.1 | 19.2 | 7.2 |
| Price/Book | 25.2 | 5.4 | 2.2 | 1.9 | 1.9 | 1.2 |
| Price/Sales | 4.9 | 1.9 | 0.9 | 0.8 | 0.9 | 0.6 |
| FCF Yield | 3.9% | 9.5% | 3.7% | 21.0% | 27.2% | 41.9% |
| Market Cap | 5.2B | 2.2B | 1.1B | 910M | 912M | 592M |
| Avg. Price | 5.99 | 3.14 | 1.77 | 0.96 | 0.98 | 0.66 |
| Year-End Price | 5.23 | 2.18 | 1.13 | 0.92 | 1.01 | 0.66 |
DR. MARTENS PLC ORD GBP0.01 passes 5 of 9 quality checks, suggesting mixed fundamentals.
DR. MARTENS PLC ORD GBP0.01 trades at 99.7x trailing earnings, compared to its 15-year median P/E of 9.8x, suggesting it is currently Expensive relative to its historical range. On a free-cash-flow basis, the stock trades at 2.4x vs a median of 10.5x. The company's 5-year average ROIC is 21.9% with a gross margin of 63.4%. Total shareholder yield (dividends) is 2.1%. At current prices, the estimated annualized return to fair value is -7.1%.
DR. MARTENS PLC ORD GBP0.01 (DOCS-L) has a current P/E ratio of 99.7, compared to its historical median P/E of 9.8. The stock is currently considered Expensive based on its historical valuation range.
DR. MARTENS PLC ORD GBP0.01 (DOCS-L) has a 5-year average return on invested capital (ROIC) of 21.9%. This indicates strong capital allocation and a potential competitive advantage.
DR. MARTENS PLC ORD GBP0.01 (DOCS-L) has a market capitalization of $592M. It is classified as a small-cap stock.
Yes, DR. MARTENS PLC ORD GBP0.01 (DOCS-L) pays a dividend with a trailing twelve-month yield of 2.12%.
Based on historical P/E analysis, DR. MARTENS PLC ORD GBP0.01 (DOCS-L) appears expensive. The current P/E of 99.7 is 921% above its historical median of 9.8. The estimated fair value CAGR (P/E method) is 9.8%.
DR. MARTENS PLC ORD GBP0.01 (DOCS-L) operates in the Apparel - Footwear & Accessories industry, within the Consumer Cyclical sector.
DR. MARTENS PLC ORD GBP0.01 (DOCS-L) reported annual revenue of $1.0 billion in its most recent fiscal year, based on SEC EDGAR filings.
DR. MARTENS PLC ORD GBP0.01 (DOCS-L) has a net profit margin of 0.6%. This is a modest margin.
DR. MARTENS PLC ORD GBP0.01 (DOCS-L) generated $248 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
DR. MARTENS PLC ORD GBP0.01 (DOCS-L) has a debt-to-equity ratio of 0.68. This indicates moderate leverage.
DR. MARTENS PLC ORD GBP0.01 (DOCS-L) reported earnings per share (EPS) of $0.01 in its most recent fiscal year.
DR. MARTENS PLC ORD GBP0.01 (DOCS-L) has a return on equity (ROE) of 1.2%. This indicates moderate shareholder returns.
DR. MARTENS PLC ORD GBP0.01 (DOCS-L) has a 5-year average gross margin of 63.4%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 5 years of financial data for DR. MARTENS PLC ORD GBP0.01 (DOCS-L), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
DR. MARTENS PLC ORD GBP0.01 (DOCS-L) has a book value per share of $0.54, based on its most recent annual SEC filing.
No recent press releases.